资讯

Alto Neuroscience’s Depression Drug Shows Positive Biomarker Results in Phase 2 Trial

Alto Neuroscience Inc. (NYSE: ANRO) is one of the best IPO stocks to buy according to Wall Street analysts. On June 26, Alto ...